[go: up one dir, main page]

DK0668769T3 - Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse - Google Patents

Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse

Info

Publication number
DK0668769T3
DK0668769T3 DK94900557T DK94900557T DK0668769T3 DK 0668769 T3 DK0668769 T3 DK 0668769T3 DK 94900557 T DK94900557 T DK 94900557T DK 94900557 T DK94900557 T DK 94900557T DK 0668769 T3 DK0668769 T3 DK 0668769T3
Authority
DK
Denmark
Prior art keywords
oak bark
oak
ions
extract
methods
Prior art date
Application number
DK94900557T
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Application granted granted Critical
Publication of DK0668769T3 publication Critical patent/DK0668769T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Road Paving Structures (AREA)
  • Laminated Bodies (AREA)
DK94900557T 1992-11-06 1993-11-04 Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse DK0668769T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (1)

Publication Number Publication Date
DK0668769T3 true DK0668769T3 (da) 2000-10-02

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900557T DK0668769T3 (da) 1992-11-06 1993-11-04 Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse

Country Status (21)

Country Link
US (1) US6149947A (da)
EP (1) EP0668769B1 (da)
JP (1) JP3640215B2 (da)
AT (1) ATE191850T1 (da)
AU (1) AU700019B2 (da)
BR (1) BR9307401A (da)
CA (1) CA2148795C (da)
CY (1) CY2231B1 (da)
CZ (1) CZ117395A3 (da)
DE (1) DE69328438T2 (da)
DK (1) DK0668769T3 (da)
ES (1) ES2147780T3 (da)
HU (1) HUT73791A (da)
MX (1) MX9306960A (da)
NO (1) NO951740L (da)
NZ (1) NZ258019A (da)
OA (1) OA10153A (da)
PL (1) PL308770A1 (da)
PT (1) PT668769E (da)
WO (1) WO1994011010A2 (da)
ZA (1) ZA938274B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
RU2125460C1 (ru) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Биостимулирующее средство
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
AU2002359529B2 (en) * 2001-11-29 2008-02-21 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
US20040023937A1 (en) * 2002-05-24 2004-02-05 Greystone Medical Group, Inc. Anti-cancer formulation
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
US20060105017A1 (en) * 2004-06-22 2006-05-18 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
ES2507070T3 (es) 2006-02-03 2014-10-14 Omp, Inc. Tratamiento antienvejecimiento utilizando composiciones de cobre y zinc
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2700990C (en) 2007-03-15 2014-08-12 Om Kataria Uterine stimulant sticks
EP3305305B1 (en) 2007-10-15 2021-06-09 HS Pharmaceuticals, LLC Silicate containing compositions and methods of treatment
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
WO2011103158A1 (en) * 2010-02-16 2011-08-25 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
WO2013012968A1 (en) 2011-07-20 2013-01-24 3M Innovative Properties Company Dressing with ion-carrying composition
WO2013016255A1 (en) * 2011-07-28 2013-01-31 3M Innovative Properties Company Wound-healing compositions and method of use
EP2744527B1 (en) 2011-08-17 2019-04-17 3M Innovative Properties Company Wound dressing with hydrophilic monomer-grafted fibers
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
RS65200B1 (sr) * 2019-03-04 2024-03-29 Aurealis Therapeutics AG Prokariotski ekspresioni sistem inducibilan hloridom
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US256847A (en) * 1882-04-25 Salve
US202246A (en) * 1878-04-09 Improvement in medical compounds
US37901A (en) * 1863-03-17 Improved liniment
US55911A (en) * 1866-06-26 Improved medical compound
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
EP0217975B1 (de) * 1985-10-08 1991-12-04 Psori-Med Ag Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
BR9307401A (pt) 1999-08-24
HU9501323D0 (en) 1996-05-28
NO951740D0 (no) 1995-05-04
NO951740L (no) 1995-06-19
US6149947A (en) 2000-11-21
PT668769E (pt) 2000-10-31
AU700019B2 (en) 1998-12-17
ES2147780T3 (es) 2000-10-01
NZ258019A (en) 1998-12-23
JPH08503462A (ja) 1996-04-16
OA10153A (en) 1996-12-18
DE69328438D1 (de) 2000-05-25
AU5550094A (en) 1994-06-08
CA2148795A1 (en) 1994-05-26
ZA938274B (en) 1994-06-09
PL308770A1 (en) 1995-08-21
WO1994011010A3 (en) 1994-09-15
CA2148795C (en) 2004-08-10
EP0668769A1 (en) 1995-08-30
EP0668769B1 (en) 2000-04-19
CY2231B1 (en) 2003-04-18
DE69328438T2 (de) 2001-01-04
ATE191850T1 (de) 2000-05-15
JP3640215B2 (ja) 2005-04-20
HUT73791A (en) 1996-09-30
WO1994011010A2 (en) 1994-05-26
CZ117395A3 (en) 1995-11-15
MX9306960A (es) 1995-01-31

Similar Documents

Publication Publication Date Title
DK0668769T3 (da) Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
PL308217A1 (en) Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
FI943805A0 (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
EP1138673A3 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
DK0778731T3 (da) Ionenpolymerer indeholdende biologisk aktive anioner
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
DE69213804D1 (de) Zusammensetzungen von Phytosterolen mit Phytosterolinen als Immunmodulatoren
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ATE381327T1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
NO890046D0 (no) Disubstituerte pyridiner.
TR28228A (tr) Deri gönlerinin islak muamelesi.
SE8400416L (sv) Kosmetiska kompositioner avsedda att forbettra naglarnas mekaniska egenskaper och ett sett att behandla naglar med kompositionerna
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
AU4042795A (en) Treatment of non-small cell lung carcinoma
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
DE59908268D1 (de) Khellin-zubereitung und deren verwendung zur topischen therapie
ATE87314T1 (de) Platin-arzneimittel.
AU543542B2 (en) Polymer compositions for treating tumours
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
MX9405923A (es) Mejoras en proceso para humectar y suavizar la piel.
GR3024709T3 (en) Novel cytarabine derivatives, their production and use